| Literature DB >> 21217883 |
Viera Nosál'ová1, Ružena Sotníková, Katarína Drábiková, Silvia Fialová, Daniela Košťálová, Silvia Banášová, Jana Navarová.
Abstract
Ischaemia and reperfusion (I/R) play an important role in human pathophysiology as they occur in many clinical conditions and are associated with high morbidity and mortality. Interruption of blood supply rapidly damages metabolically active tissues. Restoration of blood flow after a period of ischaemia may further worsen cell injury due to an increased formation of free radicals. The aim of our work was to assess macroscopically the extent of intestinal pathological changes caused by mesenteric I/R, and to study free radical production by luminol enhanced chemiluminescence (CL) of ileal samples. In further experiments, the antioxidative activity of the drugs tested was evaluated spectrophotometrically by the use of the DPPH radical. We studied the potential protective ex vivo effect of the plant origin compound arbutin as well as of the pyridoindole stobadine and its derivative SMe1EC2. I/R induced pronounced haemorrhagic intestinal injury accompanied by increase of myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAGA) activity. Compared to sham operated (control) rats, there was only a slight increase of CL response after I/R, probably in association with neutrophil increase, indicated by enhanced MPO activity. All compounds significantly reduced the peak values of CL responses of the ileal samples ex vivo, thus reducing the I/R induced increase of free radical production. The antioxidants studied showed a similar inhibitory effect on the CL response influenced by mesenteric I/R. If proved in vivo, these compounds would represent potentially useful therapeutic antioxidants.Entities:
Keywords: SMe1EC2; arbutin; chemiluminescence; ischaemia/reperfusion; stobadine
Year: 2010 PMID: 21217883 PMCID: PMC2984138 DOI: 10.2478/v10102-010-0021-3
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Figure 1The DPPH radical scavenging effect of arbutin, stobadine (STB) and its derivative SMe1EC2 expressed in percentage. Time 60 min, concentration of the compounds 5×10–8 – 5×10–4 mol/l.
Changes of intestinal myeloperoxidase and NAGA activity induced by mesenteric ischaemia/reperfusion in rats.
| small intestine | ||
|---|---|---|
| Group | intact sample | haemorrhagic sample |
| Control | 127.29 ± 10.33 | 155.00 ± 38.49 |
| I/R | 282.17 ± 24.68 | 250.18 ± 26.51 |
| Control | 8.81 ± 0.55 | 8.22 ± 0.47 |
| I/R | 10.09 ± 0.51 | 10.76 ± 0.25 |
*p<0.05 Control versus I/R, data are means ± SEM of n=5–7 for each group MPO – myeloperoxidase, NAGA-N-acetyl-β-D-glucosaminidase
Intestinal chemiluminescence in mesenteric ischaemia/reperfusion: effect of various plant origin compounds.
| Group | CL peaks ileum intact (cm/100mg) | Cl peaks ileum haemorrhagic (cm/100mg) |
|---|---|---|
| Control | 16.97 ± 9.63 | 6.41 ± 1.23 |
| I/R | 17.77 ± 3.98 | 11.12 ± 2.23 |
| I/R AR | 4.27 ± 0.89 | 1.77 ± 0.33 |
| I/R MV | 4.67 ± 0.88 | 3.97 ± 1.62 |
| I/R RA | 9.33 ± 7.15 | 5.24 ± 4.47 |
| I/R CU | 16.33 ± 6.91 | 8.29 ± 2.39 |
Data are means±SEM, n=5–6 for each group,
*p<0.05 versus I/R.
CL peaks are expressed as cm/100 mg ww from almost intact and/or haemorrhagic ileal samples. I – ischaemia, R – reperfusion, AR – arbutin, MV – mentha villosa extract, RA-rosmarinic acid, CU – curcumine (compounds+I/R in all cases).
Intestinal chemiluminescence changes induced by mesenteric ischaemia/reperfusion.
| treatment (–) | treatment (+) | % control | % inhibition | |
|---|---|---|---|---|
| I/R STO | 4.28 ± 0.82 | 1.95 ± 0.27 | 45.56 | 54.44 |
| I/R SME | 4.37 ± 1.16 | 1.00 ± 0.31 | 22.88 | 77.12 |
| I/R CAT | 4.11 ± 0.63 | 2.19 ± 0.51 | 53.28 | 46.72 |
| I/R SOD | 4.51 ± 0.69 | 4.35 ± 1.29 | 96.45 | 3.55 |
| I/R TEMPOL | 4.36 ± 1.99 | 1.81 ± 0.07 | 41.51 | 58.49 |
Ileal samples data are mean±SEM, n=5–6, with (+) or without (–) treatment. CL peak values are expressed as cm/100 mg ww, in percent of control (initial) values and percent inhibition. I-ischaemia R-reperfusion, STO-stobadine, SME-stobadine derivative SMe1EC2, AR-arbutin, CAT-catalase, SOD-superoxide dismutase.
*p<0.05 versus treatment (–).